Stocks TelegraphStocks Telegraph
Stock Ideas

The Cigna Group (CI): Stock Surged After Analyst Upgrade

By Fahim Awan
Published On December 12, 2023 1:59 PM UTC
The Cigna Group (CI): Stock Surged After Analyst Upgrade

The Cigna Group (NYSE: CI) equity experienced notable gains during the most recent trading session, marking an ascent of 16.68% to conclude the session at $301.97. This positive momentum in Cigna Group’s stock can be attributed to an upgraded rating bestowed by the esteemed analyst firm Jefferies. Notably, on Monday, Jefferies reassessed its stance on CI stock, shifting from a “Hold” to a more favorable “Buy” rating, concurrently adjusting the price target from $335 to $341.

The surge in Cigna Group (CI) stock is further linked to its decision to forego a merger arrangement in favor of implementing a shares buyback strategy. Reports emerged on Sunday confirming Cigna’s discontinuation of negotiations for the acquisition of its rival, Humana.

The termination of the deal talks was primarily attributed to the parties’ inability to reach a consensus on the pricing aspect. However, Cigna promptly disclosed its intention to initiate share repurchases. The Board of Directors of CI has sanctioned a cumulative increase of $10 billion in incremental share repurchase authorization, augmenting the company’s total share repurchase authority to $11.3 billion.

The company anticipates allocating a significant portion of its discretionary cash flow towards share repurchases in 2024. Cigna envisions executing share repurchases totaling at least $5 billion of common stock by the conclusion of the first half of 2024. Part of this repurchase is slated to transpire through an accelerated share repurchase program scheduled for the first quarter of 2024.

Cigna Group justifies its commitment to share repurchases by highlighting the perceived undervaluation of its shares, emphasizing that such buybacks represent a value-enhancing capital deployment. This strategic approach aligns with Cigna’s broader commitment to supporting high-quality care, enhancing affordability, and fostering better health outcomes.

Emphasizing a comprehensive outlook and strategic opportunities, Cigna is poised to maintain financial discipline while steadfastly executing its strategy. The company remains committed to delivering value for its shareholders and strategically investing in future endeavors.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph